StockDriftsStockDriftsTop 3 Anchorage Capital Group L L C Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| EQPT | EQUIPMENTSHARE COM INC | 77.56% | 17.77M | $349.4M | +0.00%(+0) | $20.37(+1.28%) | 2026-06-30 | |
| S | SENTINELONE INC | 18.6% | 4.94M | $83.8M | +0.00%(+0) | $51.35(-55.00%) | 2026-06-30 | |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 3.84% | 1.75M | $17.3M | +0.00%(+0) | $426.72(-98.41%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | -12.16% | -32.23% | -27.98% | -80.63% |
| Top 20 Holdings Unweighted | +12.63% | +42.86% | -0.96% | -4.71% |
Anchorage Capital Group L L C reports $450.46M in US-listed equity holdings across 3 positions in its most recent 13F filing. Its largest disclosed positions are EQPT (77.6%), S (18.6%) and DNA (3.8%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned -32.23% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Sign up free to track Anchorage Capital Group L L C, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Anchorage Capital Group L L C’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1300714). View Anchorage Capital Group L L C’s 13F filings on SEC